Previous close | 2.1400 |
Open | 2.2100 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.1700 - 2.5799 |
52-week range | 2.1100 - 7.1700 |
Volume | |
Avg. volume | 10,827 |
Market cap | 4.472M |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | N/A |
EPS (TTM) | -8.7000 |
Earnings date | N/A |
Forward dividend & yield | 0.85 (23.33%) |
Ex-dividend date | 19 Dec 2022 |
1y target est | N/A |
Medigus’ Nasdaq trading symbol will change to XYLO on April 18, 2024 Tel Aviv, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (“Medigus” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today a corporate rebranding to reflect current focus in innovation technologies. At the heart of this rebranding is a change of the Company’s name to Xylo Technologies Ltd. to embody its corporate vision and core values. The rebranding i
Tel Aviv, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology-based company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, is excited to announce a landmark achievement by its subsidiary, Charging Robotics Ltd. Which has successfully completed the installation of its wireless charging system for an automated parking system (APS). To the best of Charging Robotics’ knowledge, this is the first i
Following completion of initial production, Revoltz sets up for delivery in accordance with its distribution agreement (the “Agreement”), aiming to sell 150 vehicles in the first year of the Agreement Tel Aviv, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Revoltz Ltd, its EV joint venture, 19.9% owned by i